HomeSOBI • STO
add
Swedish Orphan Biovitrum AB (publ)
Nakaraang pagsara
kr 293.00
Sakop ng araw
kr 296.60 - kr 305.40
Sakop ng taon
kr 241.80 - kr 354.40
Market cap
106.73B SEK
Average na Volume
346.51K
P/E ratio
26.26
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 7.44B | 8.65% |
Gastos sa pagpapatakbo | 4.17B | 15.32% |
Net na kita | 1.40B | 36.16% |
Net profit margin | 18.79 | 25.35% |
Kita sa bawat share | 3.98 | 25.16% |
EBITDA | 2.34B | -6.42% |
Aktuwal na % ng binabayarang buwis | 3.27% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.14B | 26.11% |
Kabuuang asset | 75.44B | 1.91% |
Kabuuang sagutin | 35.15B | -12.48% |
Kabuuang equity | 40.30B | — |
Natitirang share | 343.44M | — |
Presyo para makapag-book | 2.50 | — |
Return on assets | 5.53% | — |
Return on capital | 7.29% | — |
Cash Flow
Net change in cash
| (SEK) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.40B | 36.16% |
Cash mula sa mga operasyon | 1.80B | 67.63% |
Cash mula sa pag-invest | -101.00M | 77.95% |
Cash mula sa financing | -1.15B | -221.23% |
Net change in cash | 546.00M | 141.59% |
Malayang cash flow | 2.90B | 375.08% |
Tungkol
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Itinatag
1939
Website
Mga Empleyado
1,806
